Lymphoma![]() Lymphoma articles1. Leukemia :: GSK's Atriance, nelarabine for leukaemias and lymphomas approved in EuropeGlaxoSmithKline announced that Atriance? (nelarabine solution for infusion) has received approval from the European Commission for the treatment of patients with T-cell acute lymphoblastic leukaemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LBL) whose disease has not responded to, or has relapsed following, treatment with at least two chemotherapy regimens. 2. Lymphoma :: Cancer researchers at the University of Pennsylvania discover what makes lymphomas tick University of Pennsylvania researchers and their colleagues at the Wistar Institute and University of Oxford have discovered the molecular process by which the PAX5 protein, necessary for lymphocyte development, promotes the growth of common lymphomas, thereby unveiling a potential new target in the fight against cancer. 3. Skin Cancer :: Rates of cutaneous T-cell lymphoma increase over 30 years The cancer known as cutaneous T-cell lymphoma became substantially more common in the United States between 1973 and 2002, according to a report in the July issue of Archives of Dermatology, one of the JAMA/Archives journals. The rates of the disease vary by race, sex and geographic area. 4. Skin Cancer :: A rare skin cancer on the rise in USA Cutaneous T-cell lymphoma, a rare and mysterious cancer, is on the rise, according to the first nationwide study of the disease in a decade. 5. Lymphoma :: Wilmot Cancer Center Expert to Discuss Lymphoma Research Lymphoma expert Richard I. Fisher, M.D., director of the James P. Wilmot Cancer Center, will discuss the role biology plays in the future treatment of lymphomas as part of a lecture series highlighting biological and biomedical research at the University of Rochester. |